Publications

Page 2 of 2
12

genotoxicity (25 POSTS)

2010 (5 POSTS)

Assessing genotoxic impurities

Robison TW. Assessing genotoxic impurities. DIA Meeting (Early drug development: Navigating the treacherous rapids). Bethesda, MD, October 2010

Characterizing and predicting carcinogenicity and mode-of-action using conventional and toxicogenomics methods

Waters MD, Jackson MA, Lea IA. 2010. Characterizing and predicting carcinogenicity and mode-of-action using conventional and toxicogenomics methods. Mutat Res 705(3):184–200; doi: 10.1016/j.mrrev.2010.04.005.

View Abstract

2009 (1 POST)

Current and future application of genetic toxicity assays: The role and value of in vitro mammalian assays

Elespuru RK, Agarwal R, Atrakchi A, Bigger CAH, Heflich RH, Jagannath D, Levy DD…Robison TW, et al. 2009. Current and future application of genetic toxicity assays: The role and value of in vitro mammalian assays. Toxicol Sci 109(2):172-179; doi: 10.1093/toxsci/kfp067.

View Abstract

2003 (1 POST)

Bezafibrate is a dual ligand for PPARalpha and PPARbeta: Studies using null mice

Peters JM, Aoyama T, Burns AM, Gonzalez FJ. 2003. Bezafibrate is a dual ligand for PPARalpha and PPARbeta: Studies using null mice. Biochim Biophys Acta 1632(1-3):80-89; doi: 10.1016/s1388-1981(03)00065-9. PMID: 12782154.

View Abstract

1991 (1 POST)

Toxicologic evaluation of cellulon fiber; Genotoxicity, pyrogenicity, acute and subchronic toxicity

Schmitt D, Frankos V, Westland J, Zoetis T. 1991. Toxicologic evaluation of cellulon fiber; Genotoxicity, pyrogenicity, acute and subchronic toxicity. J Am Coll Toxicol 10(5):541–554; doi: 10.3109/109158191090786.

View Abstract
Page 2 of 2
12